CRUKCOLcentre Profile Banner
CRUKCOLcentre Profile
CRUKCOLcentre

@CRUKCOLcentre

Followers
2K
Following
1K
Media
215
Statuses
1K

CRUK City of London Centre is a partnership between UCL, KCL, QMUL and the Crick aiming to transform cancer outcomes through effective biological therapies.

London, England
Joined March 2019
Don't wanna be here? Send us removal request.
@CRUKCOLcentre
CRUKCOLcentre
2 days
Triple negative breast cancer is the most challenging breast cancer to treat, because the collagen matrix is especially dense. This makes it harder for the immune system to attack the cancer. Understanding this phenomenon could pave the way to the development of new treatments.
0
0
0
@CRUKCOLcentre
CRUKCOLcentre
2 days
🏆 The winner of our 2025 Image Competition is @DrEllyTyler of @QMBCI, for her image 'Where Collagen Burns and Immunity Falters'! In this breast tumour tissue, collagen fibres in the extracellular matrix blaze like wildfire.
Tweet media one
Tweet media two
1
1
3
@CRUKCOLcentre
CRUKCOLcentre
18 days
Our next 'Let's Talk About. ' webinar w CRUK Scotland Centre, @MCRCnews, @CRUKCamCentre looks at the challenges of experiencing cancer or supporting a loved one, while working in c research. Thurs 2 Oct, 12-1pm. Free, all research staff & students welcome
Tweet card summary image
eventbrite.co.uk
Seminar exploring the challenges of experiencing cancer in a personal capacity and of loved ones while working in cancer research
0
2
3
@CRUKCOLcentre
CRUKCOLcentre
25 days
Congratulations to Dr Vinaya Gunasri on her BACR award! Dr Gunasri is an alumna of our Clinical Research Training Fellow PhD programme. You can read her blog here:
@vinaya_sn
Vinaya Gunasri
29 days
Thank you to the BACR for the Early Career Award Grateful to patients who make my research possible and my mentors, collaborators and funders who have supported me on this journey @jansen_marnix @trevoragraham @EszterLakatos42 @CR_UK @pathsoc @uclcancer.
1
0
2
@CRUKCOLcentre
CRUKCOLcentre
25 days
It's time for STARS! We're opening our doors to the cancer researchers of the future. Over 50 brilliant students from schools with historically low uni admissions will get hands-on lab experience at @qmbci, @uclcancer and @kingsmedicine. Find out more:
Tweet media one
0
4
9
@CRUKCOLcentre
CRUKCOLcentre
2 months
Last chance to sign-up, with registration closing 23.30 tonight (Tues 17 June). Don't miss out on the chance to learn about cancer prevention from leaders in epidemiology, behavioural science, cancer biology and oncology.
@CRUKCOLcentre
CRUKCOLcentre
3 months
Our Prevention Primer w @CR_UK brings together early-career researchers to promote inter-disciplinary collabs in cancer prevention. Co-host Prof Peter Sasieni @QMUL_WIPH told us more. 24 June, London. Register: @QMBCI @uclcancer @TheCrick @kingsmedicine
Tweet media one
0
0
1
@CRUKCOLcentre
CRUKCOLcentre
2 months
Today our world-class facilities staff gather to discuss latest research, emerging technologies, and career development. We have a packed programme covering the full scope of expertise on offer to researchers at our Centre @TheCrick @QMBCI @kingsmedicine @uclcancer
Tweet media one
Tweet media two
0
1
8
@CRUKCOLcentre
CRUKCOLcentre
2 months
RT @kingsmedicine: Researchers from King's have identified blood immune markers that may predict which melanoma patients will benefit from….
Tweet card summary image
kcl.ac.uk
New research identifies blood-based B cell and antibody signatures that could guide safer treatment for patients receiving immunotherapy.
0
4
0
@CRUKCOLcentre
CRUKCOLcentre
2 months
Update: it's not too late to grab your tickets for the Primer. Extended registration closes 23.30 on Tuesday 17 June:
0
0
0
@CRUKCOLcentre
CRUKCOLcentre
2 months
Update: it's not too late to grab your tickets for the Primer. Extended registration closes 23.30 on Tuesday 17 June:
0
0
1
@CRUKCOLcentre
CRUKCOLcentre
2 months
Update: it's not too late to grab your tickets for the Primer. Extended registration closes 23.30 on Tuesday 17 June:
0
0
0
@CRUKCOLcentre
CRUKCOLcentre
2 months
Update: it's not too late to grab your tickets for the Primer. Extended registration closes 23.30 on Tuesday 17 June:
0
0
0
@CRUKCOLcentre
CRUKCOLcentre
2 months
Update: it's not too late to grab your tickets for the Primer. Extended registration closes 23.30 on Tuesday 17 June:
0
0
0
@CRUKCOLcentre
CRUKCOLcentre
2 months
Update: it's not too late to grab your tickets for the Primer. Extended registration closes 23.30 on Tuesday 17 June:
0
0
0
@CRUKCOLcentre
CRUKCOLcentre
2 months
Artists from @csvpa, scientists from @uclcancer, and cancer patients, including Madlani Cancer Support, collaborated in February to share their stories. @CRUKCOLcentre proudly support today an exhibition showing their artistic responses to the interactions at the Cancer Institute
Tweet media one
0
0
1
@CRUKCOLcentre
CRUKCOLcentre
2 months
We're so excited about the world-leading experts speaking at our Prevention Primer, co-hosted with.@CR_UK! Taking place in London, Tues 24 June. Registration closes Weds 11 June - don't miss out! @uclcancer @QMBCI @TheCrick @kingsmedicine
Tweet media one
Tweet media two
Tweet media three
1
0
2
@CRUKCOLcentre
CRUKCOLcentre
2 months
Our Prevention Primer will take a multi-disciplinary approach to questions in Cancer Prevention, looking at prediction, vaccines and applying knowledge to wider populations. 24 June, London. Register: @QMBCI @uclcancer @kingsmedicine @TheCrick @QMUL_WIPH
Tweet media one
1
1
4
@CRUKCOLcentre
CRUKCOLcentre
3 months
Proud to co-host our Prevention Primer w @CR_UK, discussing with early-career biologists, clinicians, epidemiologists + behavioural scientists how inter-disciplinary collabs drive breakthroughs in ca prevention @QMBCI @kingsmedicine @TheCrick @uclcancer.
1
0
0
@CRUKCOLcentre
CRUKCOLcentre
3 months
RT @eriksahailab: Excited to share details of this meeting and the exciting line up of speakers. Hope to see you there. Please re-post http….
0
19
0
@CRUKCOLcentre
CRUKCOLcentre
3 months
Fascinating keynote - Prof @simonrcherry @ucdavis on total body PET. A story of tenacity and patience, resulting in tech that has benefitted >500k patients worldwide. Quantify total tumour burden, characterise immune response, and investigate multi-organ effects of therapies.
Tweet media one
Tweet media two
0
0
1